By Day 21, tumors in the control group exhibited a substantial increase in bioluminescence signal, indicating aggressive tumor progression, whereas all LA-CB1-treated groups showed significantly reduced tumor bioluminescence, with the 2 mg/kg LA-CB1 group displaying the lowest signal, reflecting the greatest inhibition of tumor growth. Here, CNR1 is linked to neoplasm.